Marcelo Mester, tcBc-sP 1 ; andré luiz gioia Morrell 1 ; andre roncon dias 1 ; Bruno zilBerstein, ecBc-sP 1 ; ulysses riBeiro Junior, tcBc-sP 1 ; iVan cecconello, ecBc-sP 1 Objective: to evaluate the clinical and pathological characteristics and survival of young patients with gastric cancer, regardless of the intention of treatment. Methods: we conducted a retrospective analysis of all gastric cancer patients undergoing any surgical treatment between 2008 and 2017. We considered patients under 45 years old as young adults and those over 45 years old, as of advanced age. Results: of the 875 patients evaluated, 84 (9.6%) were young adults and 791 (90.4%) were older. Younger patients were associated with female gender (p<0.001), lower Charlson score (p=0.002), ASA I/II (p<0.001), diffuse Lauren type (p<0.001) and poorly differentiated tumors (p<0.001). There was no difference between groups regarding treatment intention (palliative versus curative) (p=0.267) and cTNM clinical stage (p=0.120). Disease-free survival was worse in younger individuals (p=0.049), but overall survival was similar between groups (p=0.578). Multivariate analysis identified total gastrectomy, pT3/T4, pN+, and diffuse Lauren type as prognostic factors associated with worse disease-free survival and overall survival. Age was not an independent factor associated with worse prognosis. Conclusion: although younger patients had lower disease-free survival, overall survival was similar between groups, and age was not a significant independent prognostic factor.
INTRODUCTION
T he incidence of gastric cancer (GC) has been decreasing worldwide. However, it remains the fifth most common cancer in the world and still causes significant morbidity and mortality throughout several countries in Europe, Asia, and South America 1 . The main GC carcinogenesis model involves several molecular alterations induced by environmental factors including: 1) high salt intake diets (mostly with high sodium concentrations); 2) poor food conservation; 3) increase in N-nitroso compounds in the gastric mucosa; 4) antioxidants/ vitamin deficiencies (e.g. vitamin C); 5) Helicobacter pylori infection; 6) proinflammatory cytokine gene polymorphisms; 7) prolonged alcohol and tobacco consumption 2, 3 . The cumulative effect of these aggressions on the gastric epithelium over the years leads to the development of neoplasia.
Thus, GC usually has its high incidence in the sixth decade of life, in patients with chronic atrophic gastritis and intestinal metaplasia 2 .
At the same time, GC may also occur without chronic gastric inflammation as a prerequisite, especially in young adults 4 . These tumors are often associated with changes in the CDH1 gene and exhibit
Lauren's diffuse histological type. Therefore, the challenge of early diagnosis and treatment of GC also extends to young patients. Recent data have revealed that young adults gastric cancer (YAGC) accounts for 2-8% of all cancers 5, 6 . Besides the obvious social impact, YAGC calls for more and more interest due to the growing importance attached to the genetic causes of the disease. A mechanism of genetic inheritance has already been discovered and proven in a subgroup of We graded postoperative complications (POC) according to the Clavien-Dindo's classification 16 .
We classified major complications as Clavien III-IV-V.
We considered postoperative mortality when death occurred in the first 30 days after surgery or during hospital stay after the procedure.
We conducted the postoperative followup on a quarterly basis in the first year after surgery, and every six months in the following years. We performed follow-up studies for relapse detection based on the presence of symptoms. We considered loss of follow-up when patients missed their postoperative outpatient clinical appointments for more than 12 consecutive months. 
RESULTS
During the period studied, 934 patients underwent surgical or endoscopic procedures due to GC. From these, 875 (93.7%) were diagnosed as gastric adenocarcinoma and were included in this study. There were 550 males (62.9%) and 325 females (37.1%), with a mean age of 65 years (range 22-94 years) ( Figure 1 ). There were 84 (9.6%) patients who were 45-years old or younger (YAGC group), and 791 (90.4%) were older (OGC age group). These distinct cut-off values may also reflect different national policies for defining and collecting data on cancer cases in adolescents and young adults, including tumor types other than GC 19, 23 .
In the present study, we used 45 years, in agreement with most of the papers on YAGC 6, 18, 20, 21, 24, 25 . 10, 11 .
In this study, there were more females than males in the YAGC group. One of the hypotheses for this predominance refers to hormonal differences, which may contribute to women being more susceptible to the development of CG. On the other hand, it has been suggested that male preponderance in older patients derives from a prolonged exposure to carcinogens, leading to a higher incidence of Lauren's intestinal type GC 5, 17, 18, 22 .
A major questioning that exists when analyzing surgical outcomes of YAGC patients is whether this group is already diagnosed at more advanced stages. Most of the reports are confined to analyzing only those cases that have been resected, which may lead to selection bias, since more advanced cases would not be included in the analysis. To address this issue, our initial analysis included all patients submitted to any surgical or endoscopic procedure. We verified that the initial clinical stage and the frequency of surgeries with curative and palliative intent did not differ between the groups. However, a difference was evident regarding endoscopic treatment, due to the preponderance of Lauren's diffuse type cancer in the YAGC group.
Although some authors have proposed that YAGC may be diagnosed at more advanced stages due to protracted endoscopic studies of minor dyspepsia, our data showed similar TNM clinical staging and surgical treatment intent for both groups, which suggests no delay in diagnosis for YAGC 17, 22 .
D2 lymphadenectomy has the gold standard care for GC 14, 27 . The YAGC group had a greater proportion of patients submitted to D2 lymphadenectomy. Since the OGC group had more comorbidities, a greater indication of D1 lymphadenectomy is expected 28 . As the extent of lymphadenectomy influences survival, we decided to perform the survival analysis only including patients submitted to curative intent resection with D2 lymphadenectomy. In this analysis, we verified that clinicopathological characteristics were similar to the total population. The extension of gastrectomy and length of hospital stay did not differ between the two age groups. However, as expected, major POC were more common in the OGC group.
There was no difference in the neoadjuvant therapy rate between the age groups, but YAGC patients received more adjuvant chemotherapy than OGC ones, probably due to their better medical status. Additionally, the higher incidence of POC and lower ability of elderly patients to tolerate adjuvant therapy may have influence on non-adherence to postoperative chemotherapy 29 .
Accordingly, this fact may adversely affect longterm survival in OGC patients.
Although YAGC is historically associated with the idea of worse prognosis and survival, the existing data are still insufficient to indicate the need for a more aggressive approach in these cases 6 . A German study showed better survival for younger patients 11 . Conversely, Asian studies have shown that OS is equal in both age populations 5, 22, 25 .
YAGC patients may present better performance, since they allow the adoption of more aggressive multimodal treatment regimes. A meta-analysis including seven Asian and two Western studies showed that younger patients have better prognosis than older ones 20 Our study showed that YAGC was predominant in females, patients with better clinical conditions, diffuse histological type and poorly differentiated tumors. Nonetheless, there was no difference in the TNM stage, and YAGC patients underwent the same type of surgical treatment as the older ones. YAGC had worse disease-free survival, but overall survival OS was similar between the age groups, and age was not an independent factor associated with worse prognosis in GC.
